Pharma firms must stay healthy to win vaccine race
India companies have slim chance of success without government or donor funding, but stocks surge is a good sign as they rush to find cure for Covid-10 pandemic.
THE race to produce a vaccine against the novel coronavirus is featuring five Indian multinational pharmaceuticals and biotech companies and two research institutes that are aiming to deliver vaccines and super drugs at prices much below their global counterparts. So far, more than 40 companies across the world are scrambling to find a cure for the pandemic.
Indian pharma companies - which have a long tradition of produ…
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Columns
‘Competition for talent’ a poor excuse to keep key executives’ pay under wraps
OCBC should put its properties into a Reit and distribute the trust’s units to shareholders
Why a stronger US dollar is dangerous
An overstimulated US economy is asking for trouble
Too many property agents? Cap commissions on home sales
Time to study broadening of private market access